These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 571588)

  • 21. Benign breast disease: studies of prostaglandin E2, steroids, and thermographic effects of inhibitors of prostaglandin biosynthesis.
    Rolland PH; Martin PM; Rolland AM; Bourry M; Serment H
    Obstet Gynecol; 1979 Dec; 54(6):715-8. PubMed ID: 514558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Luteal phase deficiency: an inadequate endometrial response to normal hormone stimulation.
    Balasch J; Vanrell JA
    Int J Fertil; 1986; 31(5):368-71. PubMed ID: 2898441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human benign breast disease: relationships between prostaglandin E2, steroid hormones, and thermographic effects of the inhibitors of PG biosynthesis.
    Rolland PH; Martin PM; Bourry M; Rolland AM; Serment H
    Adv Prostaglandin Thromboxane Res; 1980; 6():581-4. PubMed ID: 7386292
    [No Abstract]   [Full Text] [Related]  

  • 24. Twenty-four-hour preoperative endocrine profiles in women with benign and malignant breast disease.
    Malarkey WB; Schroeder LL; Stevens VC; James AG; Lanese RR
    Cancer Res; 1977 Dec; 37(12):4655-9. PubMed ID: 922746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A study on luteal function during consecutive cycles (author's transl)].
    Ishimaru T; Morisaki M; Kohno A; Okamoto S; Nakano T; Imamura S; Oh S; Nakajima H; Yamabe T
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Nov; 33(11):1951-60. PubMed ID: 7320595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Luteal function after delayed ovulation.
    Balasch J; Creus M; Vanrell JA
    Fertil Steril; 1986 Mar; 45(3):342-4. PubMed ID: 3949033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormonal profile of benign breast disease and premenstrual mastodynia.
    Gorins A; Cordray JP
    Eur J Gynaecol Oncol; 1984; 5(1):1-10. PubMed ID: 6698047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proceedings: Serum oestradiol 17 beta in normal premenopausal women and in patients with benign and malignant breast disease.
    Skinner LG; England PC; Cottrell KM; Selwood RA
    Br J Cancer; 1974 Aug; 30(2):176-7. PubMed ID: 4419442
    [No Abstract]   [Full Text] [Related]  

  • 29. [Inadequate corpus luteum function in benign breast-diseases (author's transl)(proceedings)].
    Mauvais-Jarvis P; Ware R; Sterkers N; Tamborini A
    Ann Endocrinol (Paris); 1976; 37(4):309-10. PubMed ID: 1022191
    [No Abstract]   [Full Text] [Related]  

  • 30. Inadequate luteal phase and benign breast disease.
    Marchesoni D; Gangemi M; Mozzanega B; Paternoster D; Graziottin A; Maggino T
    Clin Exp Obstet Gynecol; 1981; 8(4):160-3. PubMed ID: 7346187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolactin secretion in benign breast diseases.
    Sitruk-Ware R; Clair F; Sterkers N; Ulmann A; Mauvais-Jarvis P
    Gynecol Endocrinol; 1987 Jun; 1(2):195-200. PubMed ID: 3140581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma oestradiol and progesterone in benign breast disease.
    Swain MC; Hayward JL; Bulbrook RD
    Eur J Cancer (1965); 1973 Aug; 9(8):553-6. PubMed ID: 4788843
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hormonal profiles and structures in normal women and in patients with benign and malignant breast diseases].
    Imayoshi E; Soga H; Nomura S; Komatsubara S; Satoh G; Teramoto S; Fukuda K; Takashima S
    Nihon Gan Chiryo Gakkai Shi; 1984 Jun; 19(5):1014-20. PubMed ID: 6501991
    [No Abstract]   [Full Text] [Related]  

  • 34. Serum oestradiol-17 beta in women with benign and malignant breast disease.
    England PC; Skinner LG; Cottrell KM; Sellwood RA
    Br J Cancer; 1974 Dec; 30(6):571-6. PubMed ID: 4447785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Midluteal progesterone/estradiol ratio as an indicator of pregnancy potential].
    Tajima C; Kawano T; Iwamasa J; Honda Y; Okamura H; Miyakita T; Koshida M
    Nihon Naibunpi Gakkai Zasshi; 1989 Nov; 65(11):1278-85. PubMed ID: 2591611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum oestradiol-17 beta and prolactin concentrations during the luteal phase in women with benign breast disease.
    Walsh PV; McDicken IW; Bulbrook RD; Moore JW; Taylor WH; George WD
    Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1345-51. PubMed ID: 6542005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum prolactin concentrations in benign breast disease throughout the menstrual cycle.
    Cole EN; Sellwood RA; England PC; Griffiths K
    Eur J Cancer (1965); 1977 Jun; 13(6):597-603. PubMed ID: 880967
    [No Abstract]   [Full Text] [Related]  

  • 38. THE ROLE OF E2/P RATIO IN THE ETIOLOGY OF FIBROCYSTIC BREAST DISEASE, MASTALGIA AND MASTODYNIA.
    Brkić M; Vujović S; Ivović M; Tančić Gajić M; Marina L; Franić Ivanišević M; Franić D
    Acta Clin Croat; 2018 Dec; 57(4):756-761. PubMed ID: 31168213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [HCG-determinations in serum and mammary cyst aspirates in women with benign breast tumors (author's transl)].
    Opri F; Post G; Kirchner H; Hammerstein J
    Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):690-3. PubMed ID: 478270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex hormones in breast disease.
    England PC; Skinner LG; Cottrell KM; Sellwood RA
    Br J Surg; 1975 Oct; 62(10):806-9. PubMed ID: 1191940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.